Sourasky Medical Center
Sourasky Medical Center
Israel, Tel Aviv
Felix Bokstein
46 Jahre der Erfahrung
Klinik ist zertifiziert :
| Israel | Türkei | Österreich | |
| Operation des Hypophysentumors | von $28,000 | von $13,500 | von $30,000 |
| Kraniotomie | von $28,500 | von $5,650 | von $20,000 |
| Gamma-Messer | von $13,800 | von $6,300 | von $32,000 |
| Entfernung von Hirntumoren | von $38,500 | von $19,710 | von $60,000 |
| Transnasale Resektion des Tumors | - | von $8,000 | von $30,000 |
Prof. Zvi Cohen ist Direktor der Abteilung für Neurochirurgie und der Einheit für Neuroonkologie am Sheba Medical Center. Er ist Neurochirurg und Experte für Neuroonkologie. Er gehört zu den „Best Doctors 2025“ von Forbes Israel. Er leitet klinische Forschung zu medikamentösen Therapien bei malignen Hirntumoren. Zudem gründete er die Gewebebank für Hirntumoren des Sheba Medical Center.
Er ist Facharzt für Neurochirurgie. Seine Ausbildung absolvierte er an der Universität Tel Aviv. Er absolvierte Fellowships in Neuroradiologie am Beth Israel und in neurochirurgischer Onkologie am MD Anderson. Sein klinisches Spektrum umfasst komplexe Tumoren des Gehirns, der Hypophyse, der Wirbelsäule und des Rückenmarks. Er verfügt über Expertise in stereotaktischen Biopsien, bildgestützten Resektionen, intraoperativer MRT, Navigationssystemen und Radiochirurgie. Er ist Mitglied der Society for Neuro-Oncology und der Israeli Association of Neurological Surgeons.
Dr. Felix Bokstein ist Leiter der Klinik für Neuroonkologie am Sourasky Medical Center (Ichilov) und spezialisiert auf komplexe Tumoren des Gehirns und des Zentralnervensystems.
Professor Constantini ist ein Experte für mikrochirurgische Operationen und pädiatrische Neurochirurgie mit einer Ausbildung in fortgeschrittener Neuroendoskopie und der Behandlung supratentorieller Tumoren.
Mit über 30 Jahren Erfahrung in der Neurochirurgie ist Professor Zvi Ram ein weltweit führender Experte für Hirntumorchirurgie, einschließlich Hypophysentumoren, am Sourasky Medical Center in Israel.
Sourasky Medical Center, Hadassah Medical Center, and Assuta Medical Center are Israel's premier facilities for pituitary adenoma treatment. These JCI-accredited institutions specialize in endoscopic transnasal resection. This minimally invasive approach allows surgeons to remove tumors through the nasal cavity without external incisions.
Bookimed Expert Insight: Sourasky Medical Center stands out because it integrates massive patient volumes with research-led care. They serve over 1.8 million patients yearly and perform 34,000 surgeries. This high frequency allows specialists like Dr. Zvi Ram to maintain expertise in complex, recurrent adenomas. Patients benefit from this concentrated experience, as surgeons manage more rare cases than smaller regional centers.
Patient Consensus: Patients note that Israeli centers often suggest aggressive minimally invasive surgery when other countries recommend waiting. Successful outcomes include hormone levels normalizing within months and significantly shorter recovery times.
A pituitary adenoma is not cancerous. These tumors are almost always benign and originate in glandular tissue. They grow slowly and do not spread to distant organs. Malignant cases, called pituitary carcinomas, represent less than 0.1% of all diagnosed pituitary growths.
Bookimed Expert Insight: Clinical data from major Israeli centers shows a strong trend toward minimally invasive techniques. Prof. Margalit Navo at Sourasky Medical Center has performed over 100 successful skull base surgeries. Similarly, Dr. Samuel Moskovichi at Hadassah Medical Center focuses on transnasal endoscopic access. This approach allows surgeons to remove benign tumors through the nose without external incisions. This significantly reduces recovery time compared to traditional craniotomy.
Patient Consensus: Many patients initially confuse the word tumor with cancer, but doctors quickly clarify that adenomas are benign. Those treated in Israel emphasize that even large 3cm tumors are usually non-cancerous and manageable with medication like cabergoline.
Primary treatment for pituitary adenoma in Israel focuses on minimally invasive transnasal resection and specialized medical management. Surgeons at JCI-accredited centers like Sourasky Medical Center achieve a 90% success rate by removing tumors through the nasal cavity. This approach eliminates external scarring and shortens hospital stays to 3 days.
Bookimed Expert Insight: Israeli medical centers demonstrate a high level of surgical specialization, with experts like Dr. Margalit Navo performing over 100 skull base procedures. Data shows that private facilities like Assuta Medical Center handle 92,000 operations annually, allowing patients to select specific senior surgeons. This choice is vital because outcomes improve significantly when a neurosurgeon performs more than 50 adenoma resections per year.
Patient Consensus: Patients note that recovery from endoscopic surgery is remarkably fast, often returning home within 72 hours. Many emphasize the importance of choosing English-fluent multidisciplinary teams to coordinate between neurosurgery and endocrinology specialists effectively.